Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway

Abstract Background Neuroinflammation and neuronal apoptosis are closely associated with a poor prognosis in patients with subarachnoid hemorrhage (SAH). We investigated the role of C–C motif chemokine receptor 2 (CCR2) in SAH. Methods Pre-processed RNA-seq transcriptome datasets GSE167110 and GSE79...

Full description

Bibliographic Details
Main Authors: Qi Tian, Yujia Guo, Shi Feng, Chengli Liu, Peibang He, Jianfeng Wang, Wenrui Han, Chen Yang, Zhan Zhang, Mingchang Li
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-022-02676-8
_version_ 1797977344112066560
author Qi Tian
Yujia Guo
Shi Feng
Chengli Liu
Peibang He
Jianfeng Wang
Wenrui Han
Chen Yang
Zhan Zhang
Mingchang Li
author_facet Qi Tian
Yujia Guo
Shi Feng
Chengli Liu
Peibang He
Jianfeng Wang
Wenrui Han
Chen Yang
Zhan Zhang
Mingchang Li
author_sort Qi Tian
collection DOAJ
description Abstract Background Neuroinflammation and neuronal apoptosis are closely associated with a poor prognosis in patients with subarachnoid hemorrhage (SAH). We investigated the role of C–C motif chemokine receptor 2 (CCR2) in SAH. Methods Pre-processed RNA-seq transcriptome datasets GSE167110 and GSE79416 from the Gene Expression Omnibus (GEO) database were screened for genes differentially expressed between mice with SAH and control mice, using bioinformatics analysis. The endovascular perforation model was performed to establish SAH. RS504393 (a CCR2 antagonist) and LY294002 (PI3K inhibitor) were administered to explore the mechanism of neuroinflammation after SAH. SAH grading, neurological scoring, brain water content and blood–brain barrier (BBB) permeability determination, enzyme-linked immunosorbent assay (ELISA), western blotting, and immunofluorescence were performed. An in vitro model of SAH was induced in H22 cells by hemin treatment. The protective mechanism of CCR2 inhibition was studied by adding RS504393 and LY294002. Clinical cerebrospinal fluid (CST) samples were detected by ELISA. Results Expression of CCR2 was upregulated in both datasets and was identified as a hub gene. CCR2 expression was significantly upregulated in the cytoplasm of neurons after SAH, both in vitro and in vivo. RS significantly reduced the brain water content and blood–brain barrier permeability, alleviated neuroinflammation, and reduced neuronal apoptosis after SAH. Additionally, the protective effects of CCR2 inhibition were abolished by LY treatment. Finally, the levels of CCR2, inflammatory factors, and apoptotic factors were elevated in the CSF of patients with SAH. CCR2 levels were associated with patient outcomes at the 6-month follow-up. Conclusion CCR2 expression was upregulated in both in vitro and in vivo SAH models. Additionally, inhibition of CCR2, at least partly through the PI3K/AKT pathway, alleviated neuroinflammation and neuronal apoptosis in vivo and in vitro. CCR2 levels in the CSF have a moderate diagnostic value for 6-month outcome prediction in patients with SAH.
first_indexed 2024-04-11T05:05:19Z
format Article
id doaj.art-7985d42715724329b202fa0cd4b4bc52
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-04-11T05:05:19Z
publishDate 2022-12-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-7985d42715724329b202fa0cd4b4bc522022-12-25T12:23:48ZengBMCJournal of Neuroinflammation1742-20942022-12-0119111610.1186/s12974-022-02676-8Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathwayQi Tian0Yujia Guo1Shi Feng2Chengli Liu3Peibang He4Jianfeng Wang5Wenrui Han6Chen Yang7Zhan Zhang8Mingchang Li9Department of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityDepartment of Rehabilitation, Renmin Hospital of Wuhan UniversityDepartment of Neurosurgery, Renmin Hospital of Wuhan UniversityAbstract Background Neuroinflammation and neuronal apoptosis are closely associated with a poor prognosis in patients with subarachnoid hemorrhage (SAH). We investigated the role of C–C motif chemokine receptor 2 (CCR2) in SAH. Methods Pre-processed RNA-seq transcriptome datasets GSE167110 and GSE79416 from the Gene Expression Omnibus (GEO) database were screened for genes differentially expressed between mice with SAH and control mice, using bioinformatics analysis. The endovascular perforation model was performed to establish SAH. RS504393 (a CCR2 antagonist) and LY294002 (PI3K inhibitor) were administered to explore the mechanism of neuroinflammation after SAH. SAH grading, neurological scoring, brain water content and blood–brain barrier (BBB) permeability determination, enzyme-linked immunosorbent assay (ELISA), western blotting, and immunofluorescence were performed. An in vitro model of SAH was induced in H22 cells by hemin treatment. The protective mechanism of CCR2 inhibition was studied by adding RS504393 and LY294002. Clinical cerebrospinal fluid (CST) samples were detected by ELISA. Results Expression of CCR2 was upregulated in both datasets and was identified as a hub gene. CCR2 expression was significantly upregulated in the cytoplasm of neurons after SAH, both in vitro and in vivo. RS significantly reduced the brain water content and blood–brain barrier permeability, alleviated neuroinflammation, and reduced neuronal apoptosis after SAH. Additionally, the protective effects of CCR2 inhibition were abolished by LY treatment. Finally, the levels of CCR2, inflammatory factors, and apoptotic factors were elevated in the CSF of patients with SAH. CCR2 levels were associated with patient outcomes at the 6-month follow-up. Conclusion CCR2 expression was upregulated in both in vitro and in vivo SAH models. Additionally, inhibition of CCR2, at least partly through the PI3K/AKT pathway, alleviated neuroinflammation and neuronal apoptosis in vivo and in vitro. CCR2 levels in the CSF have a moderate diagnostic value for 6-month outcome prediction in patients with SAH.https://doi.org/10.1186/s12974-022-02676-8ApoptosisCCR2InflammationNeuronSubarachnoid hemorrhage
spellingShingle Qi Tian
Yujia Guo
Shi Feng
Chengli Liu
Peibang He
Jianfeng Wang
Wenrui Han
Chen Yang
Zhan Zhang
Mingchang Li
Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway
Journal of Neuroinflammation
Apoptosis
CCR2
Inflammation
Neuron
Subarachnoid hemorrhage
title Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway
title_full Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway
title_fullStr Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway
title_full_unstemmed Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway
title_short Inhibition of CCR2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the PI3K/Akt pathway
title_sort inhibition of ccr2 attenuates neuroinflammation and neuronal apoptosis after subarachnoid hemorrhage through the pi3k akt pathway
topic Apoptosis
CCR2
Inflammation
Neuron
Subarachnoid hemorrhage
url https://doi.org/10.1186/s12974-022-02676-8
work_keys_str_mv AT qitian inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT yujiaguo inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT shifeng inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT chengliliu inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT peibanghe inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT jianfengwang inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT wenruihan inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT chenyang inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT zhanzhang inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway
AT mingchangli inhibitionofccr2attenuatesneuroinflammationandneuronalapoptosisaftersubarachnoidhemorrhagethroughthepi3kaktpathway